SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
04-Oct-24 4:05 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Oct-24 | Option Exercise | 3,255 | -- | -- | 3% 106.46K to 109.72K | |
05-Jul-24 4:05 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Jul-24 | Option Exercise | 3,255 | -- | -- | 3% 103.21K to 106.46K | |
11-Jun-24 2:15 PM View: | Kahn Clare Director | Solid Biosciences Inc. (SLDB) | 07-Jun-24 | Purchase | 1,100 | $7.67 | $8,441.62 | 100% 0 to 1.1K | |
05-Apr-24 4:45 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Apr-24 | Option Exercise | 3,256 | -- | -- | 3% 99.95K to 103.21K | |
30-Jan-24 5:20 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 29-Jan-24 | Option Sale | 139 | $7.99 | $1,110.61 | (< 1%) 122.76K to 122.62K | |
30-Jan-24 5:20 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-24 | Option Exercise | 388 | -- | -- | < 1% 118.48K to 118.87K | |
30-Jan-24 5:20 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-24 | Option Exercise | 3,883 | -- | -- | 3% 118.87K to 122.76K | |
12-Jan-24 5:15 PM View: | Perceptive Advisors LLC Director 10% Owner | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Purchase | 3,410,710 | $5.53 | $18,861,200.00 | 98% 3.5M to 6.91M | |
12-Jan-24 5:01 PM View: | Ra Capital Management, LLC Director 10% Owner | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Purchase | 904,160 | $5.53 | $5,000,000.00 | 27% 3.4M to 4.3M | |
12-Jan-24 5:09 PM View: | Bain Capital Life Sciences ... Director 10% Owner | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Grant Duplicate | 904,160 | $5.53 | $5,000,000.00 | 29% 3.13M to 4.03M | |
12-Jan-24 4:56 PM View: | Koppel Adam Director 10% Owner | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Grant | 904,160 | $5.53 | $5,000,000.00 | 29% 3.13M to 4.03M | |
11-Jan-24 5:43 PM View: | Tan Kevin CFO & Treasurer | Solid Biosciences Inc. (SLDB) | 09-Jan-24 | Option Sale | 3,935 | $8.20 | $32,267.00 | (30%) 13.24K to 9.31K | |
11-Jan-24 5:43 PM View: | Tan Kevin CFO & Treasurer | Solid Biosciences Inc. (SLDB) | 09-Jan-24 | Option Exercise | 11,250 | -- | -- | 564% 1.99K to 13.24K | |
05-Jan-24 7:04 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 03-Jan-24 | Option Exercise | 2,993 | -- | -- | 3% 116.63K to 119.63K | |
05-Jan-24 7:04 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 03-Jan-24 | Option Sale | 1,142 | $5.30 | $6,052.49 | (< 1%) 119.63K to 118.48K | |
05-Jan-24 7:02 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Jan-24 | Option Exercise | 15,570 | -- | -- | 18% 84.38K to 99.95K | |
05-Dec-23 2:31 PM View: | Herzich Paul Chief Technology Officer | Solid Biosciences Inc. (SLDB) | 04-Dec-23 | Planned Option Sale | 2,968 | $2.77 | $8,232.34 | (41%) 7.24K to 4.27K | |
05-Dec-23 2:32 PM View: | Howton David T Chief Operating Officer | Solid Biosciences Inc. (SLDB) | 04-Dec-23 | Planned Option Sale | 5,367 | $2.78 | $14,920.30 | (41%) 13.05K to 7.68K | |
05-Dec-23 2:30 PM View: | Hanrahan Jessie Chief Regulatory Officer | Solid Biosciences Inc. (SLDB) | 04-Dec-23 | Planned Option Sale | 4,879 | $2.78 | $13,561.70 | (41%) 11.86K to 6.98K | |
05-Dec-23 2:30 PM View: | Marlowe Jennifer CSO | Solid Biosciences Inc. (SLDB) | 04-Dec-23 | Planned Option Sale | 4,890 | $2.77 | $13,524.80 | (41%) 11.89K to 7.0K | |
05-Dec-23 2:40 PM View: | Cumbo Alexander President and CEO Director | Solid Biosciences Inc. (SLDB) | 04-Dec-23 | Planned Option Sale | 11,757 | $2.77 | $32,516.30 | (40%) 29.2K to 17.44K | |
05-Dec-23 2:32 PM View: | Howton David T Chief Operating Officer | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 13,051 | -- | -- | 100% 0 to 13.05K | |
05-Dec-23 2:30 PM View: | Hanrahan Jessie Chief Regulatory Officer | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 11,862 | -- | -- | 100% 0 to 11.86K | |
05-Dec-23 2:30 PM View: | Marlowe Jennifer CSO | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 11,888 | -- | -- | 100% 0 to 11.89K | |
05-Dec-23 2:40 PM View: | Cumbo Alexander President and CEO Director | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 28,612 | -- | -- | 4899% 0.58K to 29.2K | |
05-Dec-23 2:33 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 1,583 | -- | -- | 1% 115.05K to 116.63K | |
05-Dec-23 2:31 PM View: | Herzich Paul Chief Technology Officer | Solid Biosciences Inc. (SLDB) | 02-Dec-23 | Option Exercise | 7,238 | -- | -- | 100% 0 to 7.24K | |
05-Oct-23 3:13 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Oct-23 | Option Exercise | 15,569 | -- | -- | 23% 68.81K to 84.38K | |
06-Sep-23 4:40 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-Sep-23 | Option Exercise | 1,583 | -- | -- | 1% 111.47K to 113.06K | |
06-Jul-23 1:40 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Jul-23 | Option Exercise | 15,570 | -- | -- | 29% 53.24K to 68.81K | |
08-Jun-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-Jun-23 | Option Exercise | 1,583 | -- | -- | 1% 109.72K to 111.31K | |
08-Jun-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-May-23 | Planned Option Sale | 487 | $4.85 | $2,363.95 | (< 1%) 110.21K to 109.72K | |
08-Jun-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-May-23 | Option Exercise | 1,553 | -- | -- | 1% 108.66K to 110.21K | |
08-Jun-23 9:15 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Apr-23 | Option Exercise | 15,569 | -- | -- | 41% 37.67K to 53.24K | |
06-Mar-23 9:20 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 02-Mar-23 | Option Exercise | 1,584 | -- | -- | 2% 105.36K to 106.95K | |
31-Jan-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Planned Option Sale | 1,382 | $7.49 | $10,351.20 | (< 1%) 192.72K to 191.34K | |
31-Jan-23 9:18 PM View: | Morris Carl Ashley Chief Scientific Officer | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Planned Option Sale | 441 | $7.49 | $3,303.09 | (2%) 20.2K to 19.76K | |
31-Jan-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Option Exercise | 388 | -- | -- | < 1% 188.59K to 188.98K | |
31-Jan-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Planned Option Sale | 141 | $7.49 | $1,056.09 | (< 1%) 192.86K to 192.72K | |
31-Jan-23 9:18 PM View: | Morris Carl Ashley Chief Scientific Officer | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Option Exercise | 1,233 | -- | -- | 7% 18.97K to 20.2K | |
31-Jan-23 9:17 PM View: | Ganot Ilan Director | Solid Biosciences Inc. (SLDB) | 27-Jan-23 | Option Exercise | 3,883 | -- | -- | 2% 188.98K to 192.86K | |
05-Jan-23 10:00 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Jan-23 | Option Exercise | 1,620 | -- | -- | 4% 36.05K to 37.67K | |
05-Dec-22 6:02 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 13,172 | -- | -- | 4% 343.21K to 356.38K | |
05-Dec-22 5:02 PM View: | Ra Capital Management, LLC Director 10% Owner | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 2,573,190 | $5.93 | $15,250,000.00 | 312% 824.53K to 3.4M | |
05-Dec-22 5:46 PM View: | Cumbo Alexander President and CEO Director | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 584 | -- | -- | 100% 0 to 0.58K | |
06-Dec-22 4:41 PM View: | Perceptive Advisors LLC Director 10% Owner | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 2,601,760 | $5.86 | $15,250,000.00 | 291% 894.17K to 3.5M | |
04-Oct-22 4:50 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Oct-22 | Option Exercise | 24,312 | -- | -- | 8% 318.9K to 343.21K | |
06-Jul-22 4:40 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Jul-22 | Option Exercise | 24,313 | -- | -- | 8% 294.58K to 318.9K | |
05-Apr-22 4:32 PM View: | Smith Ian F Director | Solid Biosciences Inc. (SLDB) | 03-Apr-22 | Option Exercise | 24,313 | -- | -- | 9% 270.27K to 294.58K | |
15-Mar-22 5:12 PM View: | Schneider Joel Solomon Zev Chief Operating Officer | Solid Biosciences Inc. (SLDB) | 14-Mar-22 | Sale (Planned) | 30,504 | $1.10 | $33,554.40 | (11%) 266.77K to 236.27K |